Clinical trials
MicroRNAs clinical trials
Below are recruiting micrornas clinical trials, each written for real people, not researchers. We’re tracking 37 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05918510Recruiting
Blood and tumor study for virus markers in throat cancer
This study looks at virus-related markers and tiny gene regulators (microRNAs) in tumor tissue from people with certain throat cancers caused by human papilloma virus (HPV). It’s observational, meaning it does not change your treatment, but results may help doctors better understand these cancers and how they behave.
RomeAges 18 years+ - NCT06620016Recruiting
MicroRNA study for small testicular or post-chemo masses
This study looks at tiny molecules called microRNAs in the blood of people with either small testicular tumors (less than 2 cm) or leftover lymph node masses after chemotherapy for testicular cancer. The goal is to see if these microRNAs can help guide treatment decisions.
BolognaAges 18 years+ - NCT02253251Recruiting
Study genes linked to cancer risk and how they may be affected
This study looks at tiny genetic changes (called microRNA binding site mutations) to understand how they relate to cancer risk, prevention, and treatment. If you (or close family members) have had cancer, and you meet the study’s other requirements, your genetic information could help researchers learn how to better predict and manage cancer.
Los Angeles, CaliforniaAges 18 years+ - NCT07427537Recruiting
Studying nerve damage from chemotherapy in colorectal and lung cancer patients
This study looks for small molecules in the blood that might predict nerve damage caused by certain chemotherapies. If you have colorectal or lung cancer and are starting a specific chemo plan, this trial could help researchers understand why some people get nerve problems and others don't.
Clermont-FerrandAges 18 years+ - NCT07289282Recruiting
Study of blood markers and chemotherapy response in breast cancer
This trial is studying tiny molecules in your blood (called microRNAs) to see if they can predict how well breast cancer responds to chemotherapy given before surgery. If you are starting neoadjuvant chemotherapy, this study may help personalize your treatment.
IstanbulAges 18 years+ - NCT07260370Recruiting
Studying blood markers in cancer patients on immunotherapy
This study looks at tiny particles (microRNA) and cancer cells in the blood of people with cancer who are getting immunotherapy. It aims to find patterns that might help doctors better understand how the treatment is working.
Taoyuan CityAges 20 years+ - NCT04889053Recruiting
CT heart scan study in adults with type 2 diabetes
This trial uses a low-dose CT scan of the heart’s arteries to measure coronary artery calcification in people with type 2 diabetes. It aims to better understand heart calcium buildup and may help improve risk assessment for people with diabetes.
HengyangAges 18 years+ - NCT04914026Recruiting
MicroRNA test for testicular cancer diagnosis
This study looks at tiny genetic signals called microRNAs to see if they can help identify or track testicular cancer. It may help doctors recognize testicular cancer more accurately and decide what to do next.
BergenAges 18–70 - NCT06368154Recruiting
Studying early markers for brittle bones in newborns
This trial looks for tiny particles in the blood that might help doctors detect bone weakness in premature babies. It aims to find early signs of metabolic bone disease, which could lead to better care.
Changsha, HunanAges birth–3 days - NCT06442852Recruiting
Blood microRNA linked to Alzheimer's risk and severity
This study looks for tiny molecules (miRNAs) in your blood that might be linked to Alzheimer's disease risk and severity. It compares people with Alzheimer's to healthy volunteers to find potential early warning signs.
Wuhan, HubeiAges 65 years+ - NCT07755592Recruiting
Using a blood test to find prostate cancer early
This study uses a simple blood test to look for microRNA patterns that may help spot prostate cancer earlier and avoid unnecessary biopsies. If you have elevated PSA or suspicious findings, this test might give more information about your risk.
ShanghaiAges 18 years+ - NCT07703670Recruiting
MicroRNA markers in first episode schizophrenia
This study looks at tiny molecules called microRNAs in the blood of people having their first episode of schizophrenia. It aims to find markers that could help guide treatment choices.
Glen Oaks, New YorkAges 15–40 - NCT07616401Recruiting
Bone-Strengthening Drugs and Biomarkers in Postmenopausal Osteoporosis
This study tests two injectable medications (romosozumab and abaloparatide) that help strengthen bones in women after menopause. Researchers will also look at blood markers to understand why some women respond better to treatment than others.
Miano, LombardyAges 50 years+ - NCT07601464Recruiting
MicroRNA Changes in Liver Cancer Treated with Heat
This study examines how certain molecules in your blood and tumor tissue change when liver cancer is treated with heat ablation (a procedure that destroys tumors using heat). Understanding these changes may help doctors better predict treatment success in the future.
Bologna, Emilia-RomagnaAges 18–64 - NCT07346833Recruiting
MicroRNA in women with toxoplasmosis and mental illness
This study looks at tiny molecules in the blood (called microRNAs) that might help doctors tell the difference between mental health conditions in women who have had a past infection with the parasite Toxoplasma. The goal is to find better ways to diagnose and treat these conditions.
Banhā, El QalyoubiaAges 18–50 - NCT06864156Recruiting
Molecules and vitamin levels in long COVID with brain fog
This study looks at certain molecules (called microRNAs) and vitamin B12 levels in people who have ongoing brain-related symptoms like depression, anxiety, or fatigue after a COVID-19 infection. It may help understand why some people have long-lasting symptoms and could lead to better treatments.
Mexico City, Mexico CityAges 18–65 - NCT05346757Recruiting
Test stool DNA changes to screen or find colorectal cancer
This study checks whether a stool test that looks for tiny genetic signals can help detect colorectal cancer (or find it again after prior findings). You may be asked to provide a stool sample around the time you get a colonoscopy.
BarcelonaAges 18–80 - NCT07297134Recruiting
PTEN and Organ-Specific microRNAs in Breast Cancer
This trial looks at specific molecules (PTEN and microRNAs) in the blood to see if they help doctors understand how breast cancer spreads. If you have breast cancer (whether it has spread or not) or are healthy, you might be eligible.
Istanbul, IstanbulAges 18 years+ - NCT07255729Recruiting
Blood Test for Colon Cancer Staging
This study looks at a new blood test that may help doctors better understand how far colon cancer has spread. By testing a sample of your blood (taken before surgery), researchers hope to find patterns that predict the stage of cancer and help guide treatment decisions.
Duarte, CaliforniaAges 18 years+ - NCT06414720Recruiting
Saliva microRNA test for endometriosis on progestin therapy
This study looks at small molecules in saliva called microRNAs to see if they can help predict how well endometriosis responds to hormone therapy. It may help doctors choose the best treatment for you.
Udine, UDAges 18–45 - NCT07214246Recruiting
Follicular fluid microRNAs in egg health and aging
This study looks at tiny molecules in the fluid around your eggs that may explain how age affects fertility. By joining, you help scientists understand egg health and may get insights from your own IVF treatment.
Orlando, FloridaAges 18 years+ - NCT06544837Recruiting
Testing a new non-invasive test for women with implantation failure
This trial is testing a new, non-invasive test (called Ora) that checks when your uterine lining is ready for an embryo. It is for women who have had a failed transfer with a genetically normal embryo and are planning a frozen embryo transfer.
HanoiAges 28–45 - NCT07139171Recruiting
Plasma exosome role in thinking problems in first-episode schizophrenia
This study looks at tiny particles called exosomes in your blood and how small molecules inside them called microRNAs may affect thinking and memory in people with a first episode of schizophrenia. If you join, your blood will be used to help find new ways to understand and treat cognitive symptoms.
TianjinAges 18–65 - NCT07055984Recruiting
Predicting diabetes after kidney transplant using microRNA
This study looks at tiny molecules called microRNAs to predict if new diabetes might develop after a kidney transplant. By measuring these molecules in your blood, researchers hope to catch early signs and improve care.
MartinAges 18 years+
Hear when a new MicroRNAs trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for micrornas?
- Yes. Clin2 currently lists 37 recruiting micrornas studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a micrornas trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a micrornas trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.